David Gardiner
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Epidemiology top 5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 13
- Hepatitis B Virus Studies 6
- Liver Disease Diagnosis and Treatment 6
- Hepatology 13
- Hepatitis C virus research 13
- Co-authors
- Fiona McPhee (11 shared papers)Dennis M. Grasela (11 shared papers)Timothy Eley (11 shared papers)Megan Wind‐Rotolo (8 shared papers)Eric Lawitz (6 shared papers)C Pasquinelli (5 shared papers)Anna S. Lok (4 shared papers)Gregory T. Everson (5 shared papers)
- Journals
- Journal of Hepatology (8 papers)Vaccine (3 papers)PLoS ONE (3 papers)Clinical Infectious Diseases (2 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
David Gardiner
36 papers receiving 1.5k citations
David Gardiner's Hit Papers
Peers
Comparison fields: 5 of 88
- Hepatology 944
- Epidemiology 955
- Infectious Diseases 461
- Molecular Medicine 79
- Applied Microbiology and Biotechnology 32
Countries citing papers authored by David Gardiner
This map shows the geographic impact of David Gardiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gardiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gardiner more than expected).
Fields of papers citing papers by David Gardiner
This network shows the impact of papers produced by David Gardiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gardiner. The network helps show where David Gardiner may publish in the future.
Co-authors
The 25 scholars most cited alongside David Gardiner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1 Hit paper breakdown → | 2012 | 454 |
| 2 | 2013 | 197 | |
| 3 | 2013 | 111 | |
| 4 | 2013 | 98 | |
| 5 | 2009 | 73 | |
| 6 | 2012 | 70 | |
| 7 | 2008 | 63 | |
| 8 | 2009 | 62 | |
| 9 | 2011 | 48 | |
| 10 | 2014 | 41 | |
| 11 | 2017 | 34 | |
| 12 | 2019 | 34 | |
| 13 | 2012 | 27 | |
| 14 | 2011 | 24 | |
| 15 | 2018 | 23 | |
| 16 | 2015 | 21 | |
| 17 | 2014 | 17 | |
| 18 | 2008 | 16 | |
| 19 | 2018 | 16 | |
| 20 | 2012 | 12 |
About David Gardiner
David Gardiner is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Immunology and Molecular Biology, having authored 38 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), HIV Research and Treatment (4 papers), Immune Cell Function and Interaction (4 papers) and HIV/AIDS drug development and treatment (4 papers). The work is most often cited by research in Hepatology (944 citations), Epidemiology (955 citations), Infectious Diseases (461 citations), Molecular Medicine (79 citations) and Applied Microbiology and Biotechnology (32 citations). David Gardiner has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Fiona McPhee, Dennis M. Grasela, Timothy Eley, Megan Wind‐Rotolo, Eric Lawitz, C Pasquinelli, Anna S. Lok, Gregory T. Everson, Robert Reindollar and Dessislava I. Dimitrova. Their work appears in journals such as Journal of Hepatology, Vaccine, PLoS ONE, Clinical Infectious Diseases and JAIDS Journal of Acquired Immune Deficiency Syndromes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.